#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Glomerulonephritis chronic Immune-mediated enterocolitis Waldenstrom's macroglobulinaemia recurrent Renal cancer metastatic Mucopolysaccharidosis II Infantile spasms Henoch-Schonlein purpura nephritis Rhabdomyosarcoma recurrent Cystic fibrosis gastrointestinal disease Gastric cancer ABO haemolytic disease of newborn Antiphospholipid syndrome Prodromal Alzheimer's disease Malignant neoplasm of choroid Fontan procedure More trials…

    Learn about Rare Diseases

    Niemann-Pick disease – Treatment Angelman’s syndrome – Diagnostics Cystic fibrosis lung – Diagnostics Primary hyperoxaluria – Trials in Disease Hereditary neuropathic amyloidosis Alveolar rhabdomyosarcoma – Basic Information Synovial sarcoma recurrent – Basic Information Cholangitis sclerosing – Treatment Osteosarcoma metastatic – Basic Information Burkitt’s lymphoma – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Blomia Tropicalis Crgd-Zw800-1 Nnc0194-0499 Tetracosactide HALOBETASOL PROPIONATE Azelastine Bempedoic Acid Tryptophan Bupivacaine Hydrochloride Bicalutamide Barium Sulfate Atacicept Migalastat 99MTC-EUK-(SO3)CY5-MAS3 Adezunap Dabrafenib Acp-017 Azd2693 Sodium Sirolimus Bisacodyl More therapies…

    Learn about Your Condition

    Ejection fraction normal Muscle injury Papulopustular rosacea Renal failure Mixed-type liposarcoma Vaginal infection Palmoplantar pustulosis Paraesthesia Petit mal epilepsy Tardive dyskinesia Skin papilloma Graft infection Penile cancer Short stature Lipid metabolism disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Haga Hospital

Haga Hospital

Els Borst-Eilersplein 275, Hague, 2545 AA, Netherlands

Want to learn more about this study or check if you can participate? Contact us.

  • Study on TAR-200 and Cetrelimab for Patients with Muscle-Invasive Bladder Cancer Ineligible for or Refusing Platinum-Based Chemotherapy

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Bladder transitional cell carcinoma
    Investigated Drugs:
    • Cetrelimab
    • Gemcitabine Hydrochloride
    Belgium France Germany Italy The Netherlands Spain

  • Study on the Safety and Effectiveness of Tovinontrine for Adults with Chronic Heart Failure with Reduced Ejection Fraction

    Not recruiting

    2 1
    Investigated Drugs:
    • Tovinontrine
    Belgium Bulgaria Czechia Germany Hungary Italy +6

  • Study of Zanubrutinib and Rituximab Compared to Bendamustine and Rituximab for Patients with Untreated Mantle Cell Lymphoma Ineligible for Stem Cell Transplant

    Not recruiting

    4 1 1 1
    Investigated Drugs:
    • Zanubrutinib
    • Bendamustine Hydrochloride
    • Rituximab
    Austria Belgium France Germany Ireland Italy +5

  • Study on Obinutuzumab and Venetoclax for Elderly Patients with Chronic Lymphocytic Leukemia Unfit for Standard Treatments

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Obinutuzumab
    • Venetoclax
    The Netherlands

  • Study on the Effects of Itepekimab for Patients with Non-Cystic Fibrosis Bronchiectasis

    Not recruiting

    2 1
    Investigated Diseases:
    • Bronchiectasis
    Investigated Drugs:
    • Itepekimab
    Czechia Denmark France Germany Greece Italy +3

  • Study on the Effectiveness of Enlicitide Chloride in Reducing Cardiovascular Events in Patients with Atherosclerotic Cardiovascular Disease

    Not recruiting

    3 1
    Investigated Diseases:
    • Type IIa hyperlipidaemia
    Denmark France Germany Hungary Italy The Netherlands +3

  • Study of talazoparib and enzalutamide combination in men with DDR gene mutated metastatic castration-sensitive prostate cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Prostate cancer metastatic
    Investigated Drugs:
    • Talazoparib
    • Enzalutamide
    Belgium Bulgaria Czechia Finland France Germany +6

  • Study of Disitamab Vedotin and Pembrolizumab for Patients with Untreated Advanced Urothelial Cancer Expressing HER2

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Disitamab Vedotin
    • Carboplatin
    • Cisplatin
    Austria Belgium Czechia France Greece Hungary +7

  • Study on Semaglutide for Achieving Sinus Rhythm in Patients with Obesity and Persistent Atrial Fibrillation

    Not recruiting

    3 1
    Investigated Diseases:
    • Palpitations
    • Atrial fibrillation
    • Obesity
    Investigated Drugs:
    • Semaglutide
    The Netherlands

  • Study on Daratumumab, Cyclophosphamide, Bortezomib, and Dexamethasone for Patients with Newly Diagnosed Systemic AL Amyloidosis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Primary amyloidosis
    Investigated Drugs:
    • Anhydrous Cyclophosphamide
    • Bortezomib
    • Daratumumab
    Belgium Denmark France Germany Greece Hungary +5
Previous Page
1 … 9 10 11 12 13 14
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!